Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Comparative risk of musculoskeletal adverse reactions among new users of dipeptidyl peptidase-4 inhibitors: A retrospective cohort study.

< BACK TO ARCHIVE


2021 Jun


Explor Res Clin Soc Pharm


http://www.ncbi.nlm.nih.gov/pubmed/35481118?dopt=Abstract


2

Comparative risk of musculoskeletal adverse reactions among new users of dipeptidyl peptidase-4 inhibitors: A retrospective cohort study.

Authors

Comparative risk of musculoskeletal adverse reactions among new users of dipeptidyl peptidase-4 inhibitors: A retrospective cohort study.
Park T, Bresnahan M, Griggs SK, Chen J, Cho AH, Gousse Y, Feinglos M
Explor Res Clin Soc Pharm. 2021 Jun; 2:100022.
PMID: 35481118.

Abstract

The effects of dipeptidyl peptidase-4 inhibitors (DPP4Is) on joint pain have been controversial.
Read This Paper